Implemented in 2006, Medicare prescription drug benefit (Part D) spent $65.8 billion for prescription drugs in 2011, according to the Congressional Budget Office. But Medicare beneficiaries are overpaying by hundreds of dollars annually because of difficulties selecting the ideal prescription drug plan for their medical needs, an investigation by the University of Pittsburgh Graduate School of Public Health reveals.  Their work also could be useful in designing health insurance exchanges, which are state-regulated organizations created under the Affordable Care Act (“Obamacare”) to offer standardized health care plans.
<!–

–>

read more

via Science 2.0 Read More…

Advertisements